Microsoft’s
Explore Microsoft’s new Humanist AI Code of Conduct and join the conversation on ethical AI practices in this insightful six-week consultation.
MG Ship puts production-grade AI routing into logistics visibility, shifting the ROI debate from pilots to measurable outcomes
Discover how MG Ship’s AI-driven solutions transform logistics visibility and enhance ROI with measurable outcomes in route optimization and carrier selection.
Nvidia’s ‘compute backstop’ strategy turns chip sales into data-center financing leverage
Discover how Nvidia’s innovative strategy links chip sales and data-center financing, reshaping the AI landscape and unlocking new growth opportunities.
XPeng’s $900M robotics bet signals a shift from humanoid demos to manufacturable physical AI
XPeng’s massive investment in robotics marks a pivotal shift towards scalable physical AI, highlighting the challenges and opportunities in the evolving…
Samsung’s health
Discover how Samsung Research America’s innovative self-supervised techniques are revolutionizing health technology and enhancing user wellness.
Meta Ships Muse Glimmer: Open-Weights Local Agents Engineered for Consumer-GPU Inference
Discover how Meta’s Muse Glimmer empowers local AI agents with innovative engineering for efficient consumer-GPU inference and enhanced performance.
EU AI Act’s Article 50 Starts Enforcing
The EU’s AI Act introduces enforceable transparency duties, reshaping accountability for AI systems and enhancing user trust in digital interactions.
Insilico’s China-fast track for AI-designed drug candidates and what it signals for AI-driven discovery
Discover how Insilico Medicine is revolutionizing drug development in China with AI, cutting timelines and reshaping the future of pharmaceutical discovery.
AI funding in Q2 concentrated into a few megadeals as unicorn creation hits a four-year high
In Q2, AI funding saw a shift with megadeals dominating, while new unicorns emerged, indicating a market recalibration rather than a downturn.
Public Health Trials Put Enterprise LLMs Under the Governance Microscope With FHIR-Linked Workflows
Explore how US public health agencies are testing enterprise LLMs to ensure trust and compliance in clinical data handling before widespread adoption.